Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

FDA seeks more safety data on Vioxx successor Merck  amp; Co. said the US Food and Drug Administration has requested additional safety and efficacy information on its Vioxx successor, Arcoxia, before it considers granting US approval for the drug.
